This Article Full Text Full Text (PDF) Other Versions of this Article: IAI.01578-06v1 75/4/1713    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carbonetti, N. H. Articles by Ayala, V. I. Search for Related Content PubMed PubMed Citation Articles by Carbonetti, N. H. Articles by Ayala, V. I.

 Previous Article  |  Next Article 

Infection and Immunity, April 2007, p. 1713-1720, Vol. 75, No. 4
0019-9567/07/$08.00+0     doi:10.1128/IAI.01578-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Pertussis Toxin Targets Airway Macrophages To Promote Bordetella pertussis Infection of the Respiratory Tract

Department of Microbiology and Immunology, University of Maryland Medical School, Baltimore, Maryland,¹ Department of Cell Biology and Immunology, Free University, Amsterdam, The Netherlands²

Received 29 September 2006/ Returned for modification 4 January 2007/ Accepted 10 January 2007

Pertussis toxin (PT), a secreted virulence factor of Bordetella pertussis, ADP ribosylates mammalian G_i proteins and plays an important early role in respiratory tract infection by this pathogen in a mouse intranasal infection model. To test the hypothesis that PT targets resident airway macrophages (AM) to promote this infection, we depleted AM by intranasal administration of liposome-encapsulated clodronate prior to bacterial inoculation. This treatment enhanced respiratory tract infection by B. pertussis, even though it also induced a rapid influx of neutrophils to the airways. Strikingly, AM depletion also enhanced infection by mutant strains deficient in PT production or activity to the same level as the wild-type infection, indicating that AM may be the primary target cells for PT in promoting infection. The enhancing effect of clodronate-liposome treatment on infection (i) was shown to be due to macrophage depletion rather than neutrophil influx; (ii) was observed for both tracheal infection and lung infection; (iii) was observed during the early and peak phases of the infection but was lost by day 14 postinoculation, during clearance of the infection; (iv) persisted for at least 1 week (prior to bacterial inoculation); and (v) was equivalent in magnitude to the effect of PT pretreatment and the effects were not additive, consistent with the idea that PT targets AM. We found that PT efficiently ADP ribosylated AM G proteins both in vitro and after intranasal administration of PT in mice and that the duration of G protein modification in vivo was equivalent to the duration of the enhancing effect of PT treatment on the bacterial infection. Collectively, these observations indicate that PT targets AM to promote early infection of the respiratory tract by B. pertussis.

Published ahead of print on 22 January 2007.

Editor: A. D. O'Brien

This article has been cited by other articles:

• Goebel, E. M., Wolfe, D. N., Elder, K., Stibitz, S., Harvill, E. T. (2008). O Antigen Protects Bordetella parapertussis from Complement. Infect. Immun. 76: 1774-1780 [Abstract] [Full Text]  
• Mocny, J. C., Olson, J. S., Connell, T. D. (2007). Passively Released Heme from Hemoglobin and Myoglobin Is a Potential Source of Nutrient Iron for Bordetella bronchiseptica. Infect. Immun. 75: 4857-4866 [Abstract] [Full Text]  
• MacArthur, I., Mann, P. B., Harvill, E. T., Preston, A. (2007). IEIIS Meeting minireview: Bordetella evolution: lipid A and Toll-like receptor 4. Innate Immunity 13: 243-247 [Abstract]